Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses findings suggesting possible DMT risk for MS patients over age 45.
Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the Ed Tobias column, MS Wire, on travel during Covid-19: Should we stay or should we go?
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)

Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

http://ChangesInRMS.com

=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör MS News Today. Innehållet i podden är skapat av MS News Today och inte av, eller tillsammans med, Poddtoppen.